arrow_back Back Filing freshness 10-Q FY 2019 SEC EDGAR

download Export Data

BetterLife Pharma Inc.

BETRF

— Price unavailable

14 Visible periods

19 Metrics

Absolute Benchmarks

Price Chart

insights

Verdict pending

Sync financial data to generate a health grade for this company.

auto_awesome

Analytical Summary

On an absolute basis, BetterLife Pharma Inc. shows solid but mixed fundamentals. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC None

FCF / Share None

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

14-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-121.18K

↑ +98.1% —

FCF / Share Free cash flow per share

$-0.00

↑ +48.2% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2019 Jan 31, 2019 10-K ↗	FY 2018 Jan 31, 2018 10-K ↗	FY 2017 Jan 31, 2017 10-K ↗	FY 2016 Jan 31, 2016 10-K ↗	FY 2015 Jan 31, 2015 10-K ↗	FY 2014 Jan 31, 2014 10-K ↗	FY 2013 Jan 31, 2013 10-K ↗	FY 2012 Jan 31, 2012 10-K ↗	FY 2011 Jan 31, 2011 10-K ↗	FY 2010 Jan 31, 2010 10-K ↗	FY 2009 Jan 31, 2009 10-K ↗	FY 2008 Jan 31, 2008 10-K ↗	FY 2007 Jan 31, 2007 10-K ↗	FY 2002 Jun 9, 2002 10-K ↗
EPS Growth YoY (%)	—	—	—	-10.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	—	98.1% Excellent ↑ Excellent Improving Year-over-year change in net income	26.8% Excellent Excellent Year-over-year change in net income	-659.8% Weak Weak Year-over-year change in net income	—	—	N/M	N/M	-2416.4% Weak ↓ Weak Declining Year-over-year change in net income	81.6% Excellent Excellent Year-over-year change in net income	-433.3% Weak Weak Year-over-year change in net income	—	—	—
FCF Growth YoY (%)	—	—	—	48.2% Excellent Excellent Year-over-year change in free cash flow	—	—	-268.6% Weak Weak Year-over-year change in free cash flow	-4.1% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2019 Jan 31, 2019 10-K ↗	FY 2018 Jan 31, 2018 10-K ↗	FY 2017 Jan 31, 2017 10-K ↗	FY 2016 Jan 31, 2016 10-K ↗	FY 2015 Jan 31, 2015 10-K ↗	FY 2014 Jan 31, 2014 10-K ↗	FY 2013 Jan 31, 2013 10-K ↗	FY 2012 Jan 31, 2012 10-K ↗	FY 2011 Jan 31, 2011 10-K ↗	FY 2010 Jan 31, 2010 10-K ↗	FY 2009 Jan 31, 2009 10-K ↗	FY 2008 Jan 31, 2008 10-K ↗	FY 2007 Jan 31, 2007 10-K ↗	FY 2002 Jun 9, 2002 10-K ↗
FCF / Net Income (x)	—	3.26x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.06x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.04x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.24x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.10x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.04x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2019 Jan 31, 2019 10-K ↗	FY 2018 Jan 31, 2018 10-K ↗	FY 2017 Jan 31, 2017 10-K ↗	FY 2016 Jan 31, 2016 10-K ↗	FY 2015 Jan 31, 2015 10-K ↗	FY 2014 Jan 31, 2014 10-K ↗	FY 2013 Jan 31, 2013 10-K ↗	FY 2012 Jan 31, 2012 10-K ↗	FY 2011 Jan 31, 2011 10-K ↗	FY 2010 Jan 31, 2010 10-K ↗	FY 2009 Jan 31, 2009 10-K ↗	FY 2008 Jan 31, 2008 10-K ↗	FY 2007 Jan 31, 2007 10-K ↗	FY 2002 Jun 9, 2002 10-K ↗
Return on Invested Capital (%)	—	1826.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	322.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	2063.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	170.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	—	-273.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4540.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8097.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-9287.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	—	267.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1680%)	—	—	—	—	—	-138.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1023%)	295.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1869%)	—	—	-73.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-592%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2019 Jan 31, 2019 10-K ↗	FY 2018 Jan 31, 2018 10-K ↗	FY 2017 Jan 31, 2017 10-K ↗	FY 2016 Jan 31, 2016 10-K ↗	FY 2015 Jan 31, 2015 10-K ↗	FY 2014 Jan 31, 2014 10-K ↗	FY 2013 Jan 31, 2013 10-K ↗	FY 2012 Jan 31, 2012 10-K ↗	FY 2011 Jan 31, 2011 10-K ↗	FY 2010 Jan 31, 2010 10-K ↗	FY 2009 Jan 31, 2009 10-K ↗	FY 2008 Jan 31, 2008 10-K ↗	FY 2007 Jan 31, 2007 10-K ↗	FY 2002 Jun 9, 2002 10-K ↗
Interest Coverage (x)	—	-38.31x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-516.56x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-1.81x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—
Net Debt (USD)	—	$-64.51K	$-112.42K	$-71.64K	$-839.00	$-935.00	$-475.00	$-2.06K	$-15.04K	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2019 Jan 31, 2019 10-K ↗	FY 2018 Jan 31, 2018 10-K ↗	FY 2017 Jan 31, 2017 10-K ↗	FY 2016 Jan 31, 2016 10-K ↗	FY 2015 Jan 31, 2015 10-K ↗	FY 2014 Jan 31, 2014 10-K ↗	FY 2013 Jan 31, 2013 10-K ↗	FY 2012 Jan 31, 2012 10-K ↗	FY 2011 Jan 31, 2011 10-K ↗	FY 2010 Jan 31, 2010 10-K ↗	FY 2009 Jan 31, 2009 10-K ↗	FY 2008 Jan 31, 2008 10-K ↗	FY 2007 Jan 31, 2007 10-K ↗	FY 2002 Jun 9, 2002 10-K ↗
Basic EPS, GAAP (USD)	—	—	—	$-0.11	$-0.10	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	—	—	$-0.00	$-0.00	—	$-0.01	$-0.00	$-0.00	—	—	—	—	—
Book Value per Share (USD)	—	$-0.00	$-0.02	$-0.00	$-0.00	—	$-0.02	$-0.03	$-0.04	—	—	—	—	—
Tangible Book Value per Share (USD)	—	$-0.00	$-0.02	$-0.00	$-0.00	—	$-0.02	$-0.03	$-0.04	—	—	—	—	—
Basic Weighted Avg Shares (shares)	—	—	—	77.72M	11.60M	—	35.77M	33.94M	28.04M	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2019 Jan 31, 2019 10-K ↗	FY 2018 Jan 31, 2018 10-K ↗	FY 2017 Jan 31, 2017 10-K ↗	FY 2016 Jan 31, 2016 10-K ↗	FY 2015 Jan 31, 2015 10-K ↗	FY 2014 Jan 31, 2014 10-K ↗	FY 2013 Jan 31, 2013 10-K ↗	FY 2012 Jan 31, 2012 10-K ↗	FY 2011 Jan 31, 2011 10-K ↗	FY 2010 Jan 31, 2010 10-K ↗	FY 2009 Jan 31, 2009 10-K ↗	FY 2008 Jan 31, 2008 10-K ↗	FY 2007 Jan 31, 2007 10-K ↗	FY 2002 Jun 9, 2002 10-K ↗
Working Capital (USD)	—	—	$-1.48M	—	—	—	$-657.58K	$-864.20K	$-111.89K	—	—	—	—	—
Total Equity (USD)	—	$-45.38K	$-1.47M	$-328.99K	$-54.52K	$-672.01K	$-674.64K	$-1.02M	$-1.02M	$4.17K	$29.72K	$166.01K	$166.01K	$0.00

📋 What is driving earnings? 3 metrics

Metric	FY 2019 Jan 31, 2019 10-K ↗	FY 2018 Jan 31, 2018 10-K ↗	FY 2017 Jan 31, 2017 10-K ↗	FY 2016 Jan 31, 2016 10-K ↗	FY 2015 Jan 31, 2015 10-K ↗	FY 2014 Jan 31, 2014 10-K ↗	FY 2013 Jan 31, 2013 10-K ↗	FY 2012 Jan 31, 2012 10-K ↗	FY 2011 Jan 31, 2011 10-K ↗	FY 2010 Jan 31, 2010 10-K ↗	FY 2009 Jan 31, 2009 10-K ↗	FY 2008 Jan 31, 2008 10-K ↗	FY 2007 Jan 31, 2007 10-K ↗	FY 2002 Jun 9, 2002 10-K ↗
Depreciation Expense (USD)	—	—	—	$322.00	$409.00	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	—	$-121.18K	$-6.28M	$-8.58M	$-1.13M	—	$-2.16M	$1.42M	$-3.02M	$-120.13K	$-653.76K	$-122.58K	—	—
Operating Cash Flow (USD)	—	$-395.60K	$-377.78K	$-163.94K	$-47.26K	—	$-527.69K	$-135.85K	$-107.75K	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 14 years · 42 quarters

BetterLife Pharma Inc.

Analytical Summary

14-Year Financial Trajectory

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare BETRF with peers